Finally, the validation of genes CENPA and HJURP,, pivotal for chromosomestructure and stability, shows a significant decrease in expressionpostcombination therapy, further confirming the potential synergisticinhibition of neuroblastoma growth through multiple pathways. This evidence concerns the gene CENPA and neuroblastoma.